PUBLIC RESEARCH DOSSIER
SLS · Nasdaq塞拉斯生命科学
Manufacturing · Pharmaceutical Preparations完成交易日收盘US$8.87+3.74%行情日期 2026-11-03 · 非实时
公开资料页汇总塞拉斯生命科学（SLS）的已发布行情、估值、风险、财务摘要与同业对比。行情截至2026-11-03，非实时；缺失值不按零处理。
股价走势
复权收盘价（美元）
2025-10-31 — 2026-11-03253 个交易日样本
SLSUS$8.87
查看图表数据
| 日期 | SLS |
|---|---|
| 2025-10-31 | 1.82 |
| 2025-11-03 | 1.79 |
| 2025-11-04 | 1.66 |
| 2025-11-05 | 1.68 |
| 2025-11-06 | 1.62 |
| 2025-11-07 | 1.59 |
| 2025-11-10 | 1.5 |
| 2025-11-11 | 1.51 |
| 2025-11-12 | 1.49 |
| 2025-11-13 | 1.46 |
| 2025-11-14 | 1.43 |
| 2025-11-17 | 1.41 |
| 2025-11-18 | 1.59 |
| 2025-11-19 | 1.52 |
| 2025-11-20 | 1.46 |
| 2025-11-21 | 1.53 |
| 2025-11-24 | 1.55 |
| 2025-11-25 | 1.44 |
| 2025-11-26 | 1.46 |
| 2025-11-28 | 1.62 |
| 2025-12-01 | 1.5 |
| 2025-12-02 | 1.39 |
| 2025-12-03 | 1.54 |
| 2025-12-04 | 1.74 |
| 2025-12-05 | 1.74 |
| 2025-12-08 | 1.82 |
| 2025-12-09 | 1.9 |
| 2025-12-10 | 1.96 |
| 2025-12-11 | 2.01 |
| 2025-12-12 | 2.03 |
| 2025-12-15 | 2.04 |
| 2025-12-16 | 2.2 |
| 2025-12-17 | 2.11 |
| 2025-12-18 | 2.34 |
| 2025-12-19 | 2.36 |
| 2025-12-22 | 2.64 |
| 2025-12-23 | 2.77 |
| 2025-12-24 | 2.84 |
| 2025-12-26 | 2.87 |
| 2025-12-29 | 3.35 |
| 2025-12-30 | 3.31 |
| 2025-12-31 | 3.77 |
| 2026-01-02 | 4.35 |
| 2026-01-05 | 5 |
| 2026-01-06 | 4.1 |
| 2026-01-07 | 4.04 |
| 2026-01-08 | 3.86 |
| 2026-01-09 | 3.46 |
| 2026-01-12 | 4.11 |
| 2026-01-13 | 4.15 |
| 2026-01-14 | 4.11 |
| 2026-01-15 | 3.84 |
| 2026-01-16 | 3.98 |
| 2026-01-20 | 4.32 |
| 2026-01-21 | 4.58 |
| 2026-01-22 | 4.51 |
| 2026-01-23 | 4.26 |
| 2026-01-26 | 4.3 |
| 2026-01-27 | 4.4 |
| 2026-01-28 | 3.97 |
| 2026-01-29 | 3.89 |
| 2026-01-30 | 3.77 |
| 2026-02-02 | 3.97 |
| 2026-02-03 | 4.16 |
| 2026-02-04 | 3.82 |
| 2026-02-05 | 3.53 |
| 2026-02-06 | 3.73 |
| 2026-02-09 | 3.81 |
| 2026-02-10 | 3.76 |
| 2026-02-11 | 3.67 |
| 2026-02-12 | 3.55 |
| 2026-02-13 | 3.59 |
| 2026-02-17 | 3.66 |
| 2026-02-18 | 3.79 |
| 2026-02-19 | 4.04 |
| 2026-02-20 | 4.15 |
| 2026-02-23 | 4.5 |
| 2026-02-24 | 4.74 |
| 2026-02-25 | 4.55 |
| 2026-02-26 | 4.92 |
| 2026-02-27 | 4.93 |
| 2026-03-02 | 5.05 |
| 2026-03-03 | 5.31 |
| 2026-03-04 | 5.54 |
| 2026-03-05 | 5.28 |
| 2026-03-06 | 5.53 |
| 2026-03-09 | 5.96 |
| 2026-03-10 | 5.82 |
| 2026-03-11 | 5.48 |
| 2026-03-12 | 5.03 |
| 2026-03-13 | 5.37 |
| 2026-03-16 | 5.36 |
| 2026-03-17 | 5.04 |
| 2026-03-18 | 4.95 |
| 2026-03-19 | 5.2 |
| 2026-03-20 | 4.76 |
| 2026-03-23 | 5.48 |
| 2026-03-24 | 5 |
| 2026-03-25 | 5.3 |
| 2026-03-26 | 4.95 |
| 2026-03-27 | 4.37 |
| 2026-03-30 | 4.01 |
| 2026-03-31 | 4.23 |
| 2026-04-01 | 4.21 |
| 2026-04-02 | 4.13 |
| 2026-04-06 | 4.53 |
| 2026-04-07 | 4.51 |
| 2026-04-08 | 4.86 |
| 2026-04-09 | 5.05 |
| 2026-04-10 | 4.76 |
| 2026-04-13 | 4.76 |
| 2026-04-14 | 4.86 |
| 2026-04-15 | 4.91 |
| 2026-04-16 | 4.93 |
| 2026-04-17 | 5.22 |
| 2026-04-20 | 4.99 |
| 2026-04-21 | 5.03 |
| 2026-04-22 | 4.78 |
| 2026-04-23 | 4.64 |
| 2026-04-24 | 4.46 |
| 2026-04-27 | 4.88 |
| 2026-04-28 | 4.88 |
| 2026-04-29 | 4.67 |
| 2026-04-30 | 4.95 |
| 2026-05-01 | 4.93 |
| 2026-05-04 | 5.02 |
| 2026-05-05 | 4.87 |
| 2026-05-06 | 5.15 |
| 2026-05-07 | 4.93 |
| 2026-05-08 | 5.01 |
| 2026-05-11 | 5.25 |
| 2026-05-12 | 5.22 |
| 2026-05-13 | 6.53 |
| 2026-05-14 | 7.42 |
| 2026-05-15 | 7.08 |
| 2026-05-18 | 7.29 |
| 2026-05-19 | 7.59 |
| 2026-05-20 | 8.97 |
| 2026-05-21 | 7.56 |
| 2026-05-22 | 7.78 |
| 2026-05-26 | 8.12 |
| 2026-05-27 | 8.58 |
| 2026-05-28 | 9.18 |
| 2026-05-29 | 9.31 |
| 2026-06-01 | 9.07 |
| 2026-06-02 | 8.33 |
| 2026-06-03 | 8.19 |
| 2026-06-04 | 9.04 |
| 2026-06-05 | 8.23 |
| 2026-06-08 | 7.98 |
| 2026-06-09 | 7.68 |
| 2026-06-10 | 7.15 |
| 2026-06-11 | 7.75 |
| 2026-06-12 | 7.83 |
| 2026-06-15 | 7.73 |
| 2026-06-16 | 7.53 |
| 2026-06-17 | 7.76 |
| 2026-06-18 | 8.05 |
| 2026-06-22 | 8.53 |
| 2026-06-23 | 9.07 |
| 2026-06-24 | 9.17 |
| 2026-06-25 | 10.53 |
| 2026-06-26 | 12.39 |
| 2026-06-29 | 15.45 |
| 2026-06-30 | 14.76 |
| 2026-07-01 | 13.27 |
| 2026-07-02 | 14.98 |
| 2026-07-06 | 13.94 |
| 2026-07-07 | 13.5 |
| 2026-07-08 | 13.76 |
| 2026-07-09 | 13.51 |
| 2026-07-10 | 12.76 |
| 2026-07-13 | 12.62 |
| 2026-07-14 | 13.39 |
| 2026-07-15 | 12.79 |
| 2026-07-16 | 11.75 |
| 2026-07-17 | 13.19 |
| 2026-07-20 | 12.48 |
| 2026-07-21 | 12.9 |
| 2026-07-22 | 12.08 |
| 2026-07-23 | 12.34 |
| 2026-07-24 | 11.32 |
| 2026-07-27 | 10.84 |
| 2026-07-28 | 10.09 |
| 2026-07-29 | 10.1 |
| 2026-07-30 | 10.29 |
| 2026-07-31 | 10.01 |
| 2026-08-03 | 11.22 |
| 2026-08-04 | 11.81 |
| 2026-08-05 | 11.86 |
| 2026-08-06 | 11.7 |
| 2026-08-07 | 12.01 |
| 2026-08-10 | 11.04 |
| 2026-08-11 | 11.05 |
| 2026-08-12 | 11.77 |
| 2026-08-13 | 12.36 |
| 2026-08-14 | 12.78 |
| 2026-08-17 | 13 |
| 2026-08-18 | 13.1 |
| 2026-08-19 | 13.85 |
| 2026-08-20 | 13.4 |
| 2026-08-21 | 15.46 |
| 2026-08-24 | 14.33 |
| 2026-08-25 | 14.09 |
| 2026-08-26 | 13.73 |
| 2026-08-27 | 15.21 |
| 2026-08-28 | 13.21 |
| 2026-08-31 | 13.34 |
| 2026-09-01 | 13.22 |
| 2026-09-02 | 14.16 |
| 2026-09-03 | 13.7 |
| 2026-09-04 | 13.86 |
| 2026-09-08 | 13.96 |
| 2026-09-09 | 13.95 |
| 2026-09-10 | 13.49 |
| 2026-09-11 | 11.55 |
| 2026-09-14 | 11.73 |
| 2026-09-15 | 11.29 |
| 2026-09-16 | 11.66 |
| 2026-09-17 | 11.53 |
| 2026-09-18 | 11.49 |
| 2026-09-21 | 11.37 |
| 2026-09-22 | 12.02 |
| 2026-09-23 | 11.52 |
| 2026-09-24 | 11.98 |
| 2026-09-25 | 11.61 |
| 2026-09-28 | 11.59 |
| 2026-09-29 | 11.51 |
| 2026-09-30 | 12.31 |
| 2026-10-01 | 11.33 |
| 2026-10-02 | 11.74 |
| 2026-10-05 | 11.63 |
| 2026-10-06 | 11.34 |
| 2026-10-07 | 11.31 |
| 2026-10-08 | 11.26 |
| 2026-10-09 | 11.65 |
| 2026-10-12 | 11.93 |
| 2026-10-13 | 12.41 |
| 2026-10-14 | 11.88 |
| 2026-10-15 | 11.34 |
| 2026-10-16 | 9.98 |
| 2026-10-19 | 10.49 |
| 2026-10-20 | 11.98 |
| 2026-10-21 | 12.14 |
| 2026-10-22 | 11.35 |
| 2026-10-23 | 11.54 |
| 2026-10-26 | 11.34 |
| 2026-10-27 | 12.17 |
| 2026-10-28 | 10.38 |
| 2026-10-29 | 10.16 |
| 2026-10-30 | 9.68 |
| 2026-11-02 | 8.55 |
| 2026-11-03 | 8.87 |
1、3、6、12个月分别按21、63、126、252个交易日取区间；缺失日期不从区间外补齐。
使用已有每日复权收盘样本，非实时行情；图中价格可能与未复权收盘报价不同。
01 · MARKET FRAME
行情、估值与风险
基于已完成交易日和已发布财务资料
区间涨跌幅
区间涨跌幅使用复权收盘价；估值和风险指标缺失时显示为—，不按零处理。
02 · FINANCIAL TRACE
财务摘要
公开页仅显示最近3个已校验报告期
年度财务走势
百万美元 · 年度报告期
所选指标暂无已校验的年度资料，缺失值不按零处理。
| 指标 | 2026-08-10 | 2026-06-30 | 2025-12-31 | 2025-08-11 | 2025-06-30 | 2024-12-31 | 2024-08-12 | 2024-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| 营收 | — | — | — | — | — | — | — | — | — |
| 净利润 | — | — | -26.9 | — | — | -30.9 | — | — | -37.3 |
| 自由现金流 | — | — | — | — | — | — | — | — | — |
| 股份数 | 201.9 | — | — | 105.3 | — | — | 64.3 | — | — |
| 债务 | — | — | — | — | — | — | — | — | — |
| 总资产 | — | 145.4 | — | — | 32.3 | — | — | 15.1 | — |
金额及股份数均以百万为单位。缺失或待核验数据不按零处理。
03 · PEER SET
同业对比
同一细分行业中市值最接近的公司
| 公司 | 市值 | 近250日涨跌幅 | 市盈率 | 距52周高点 | 波动率 |
|---|---|---|---|---|---|
| STOKStoke Therapeutics, Inc. | US$1.7B | +6.5% | — | -29.6% | +56.3% |
| ZBIO泽纳斯生物医药 | US$1.8B | -5.2% | — | -34.3% | +94.8% |
| AGIO阿吉奥斯制药 | US$1.9B | -22% | — | -31.4% | +79.1% |
| PGEN普雷西根 | US$1.9B | +35.3% | — | -38.7% | +83.2% |
同业由已覆盖公司的行业分类和市值接近度确定，仅用于横向研究；缺失数据不按零处理。